Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Talaris Therapeutics, Inc. (TALS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.50+0.18 (+1.17%)
At close: 4:00PM EDT
15.50 0.00 (0.00%)
After hours: 04:33PM EDT
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Talaris Therapeutics to Participate at Two Upcoming Virtual Investor Conferences

    BOSTON and LOUISVILLE, Ky., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and metabolic disorders, today announced that members of its senior management team will participate at the following investor conferences: Morgan Stanley Virtual

  • GlobeNewswire

    Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update

    On track to provide FREEDOM-1 initial clinical update, initiate FREEDOM-2 and FREEDOM-3 trials, and to disclose additional indication for FCR001 before year-endBOSTON and LOUISVILLE, Ky., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune and

  • Simply Wall St.

    Here's What Talaris Therapeutics, Inc.'s (NASDAQ:TALS) Shareholder Ownership Structure Looks Like

    The big shareholder groups in Talaris Therapeutics, Inc. ( NASDAQ:TALS ) have power over the company. Insiders often...

Advertisement
Advertisement